This phase II trial tests whether ruxolitinib works to shrink tumors in patients with T-cell large granular lymphocyte leukemia. Ruxolitinib may stop the growt…

T-Cell Large Granular Lymphocyte Leukemia

~Estimated

~$10 – $7,500

Jonathan BrammerNCT05592015

Phase 1

Phase I Multicenter Study of Ruxolitinib and Duvelisib in Relapsed or Refractory T- or NK-Cell Lymphomas

This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if a…

T-cell LymphomasNK-Cell LymphomasT-cell Prolymphocytic Leukemia+1 more

~Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT05010005